SARS-CoV-2 (COVID-19) Spike Glycoprotein-S2, Recombinant protein
Product Specifications
Background
A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV was found in the fish market at the city of Wuhan, Hubei province of China on December 2019. The 2019-nCoV shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity so thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2) in humans. While bats are possibly the host of 2019-nCoV, researchers suspect that animal from the ocean sold at the seafood market was an intermediate host. RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus.
Tag
Fc tag
Type
Recombinant Proteins
Source
HEK293 cells
Field of Research
Infectious Disease, COVID-19
Purity
>85% pure as determined SDS-PAGE. Purified by Protein-G chromatographic technique.
Buffer
NCoV-S2 protein solution is supplied in DPBS.
Shipping Conditions
Blue Ice
Storage Conditions
Store in working aliquots at -20˚ C. Avoid freeze/thaw cycles.
Product Datasheet
https://www.prosci-inc.com/?datasheet_sku=39-112
Species
SARS-CoV-2 (COVID-19, 2019-nCoV) Spike Protein
Physical Properties
Liquid
CAS Number
9000-83-3
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
